SCHEMBL294226

SCHEMBL294226

Cc1ccccc1N1CC(C)(C)NCC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.49
CRBN Q96SW2 1/20 0.49
MAPT P10636 3/20 0.45
OPRM1 P35372 1/20 0.44
OPRL1 P41146 1/20 0.44
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
ALOX5 P09917 2/20 0.40
MGLL Q99685 1/20 0.39
KDM4E B2RXH2 1/20 0.39
P2RX7 Q99572 1/20 0.38
ELANE P08246 1/20 0.37
LMNA P02545 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CASP3 P42574 1/20 0.37
CASP6 P55212 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL291891 0.83 LMNA (0.47) MAPTOPRM1OPRL1KMT2AMEN1
SCHEMBL292960 0.83 MEN1 (0.53) OPRM1OPRL1KMT2AMEN1SMN1; SMN2
SCHEMBL292679 0.83 HSD11B1 (0.46) MAPTOPRM1SMN1; SMN2ALOX5MGLL
SCHEMBL292438 0.82 HSD17B10 (0.57) MAPTOPRM1KMT2AMEN1KDM4E
SCHEMBL293635 0.81 RECQL (0.40) OPRM1OPRL1KMT2AMEN1P2RX7
SCHEMBL292189 0.81 ALDH1A1 (0.48) MAPTKMT2AMEN1SMN1; SMN2MGLL
SCHEMBL291894 0.80 MAPT (0.43) DDB1CRBNMAPTOPRM1KMT2A
SCHEMBL292828 0.80 HTR7 (0.40) P2RX7
SCHEMBL292701 0.80 AR (0.44) MAPTKMT2AMEN1KDM4EL3MBTL1
SCHEMBL291908 0.80 HTR7 (0.40) MAPTOPRM1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
WO-2011065519-A1 SUBSTITUTED OXOPIPERAZINE COMPOUND 第一三共株式会社 (JP) 2011-06-03 WO disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 DDB1 3193/4885CRBN 961/4885MAPT 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.